Cargando…
Current clinical trials testing the combination of immunotherapy with radiotherapy
Increasing evidence demonstrates that radiation acts as an immune stimulus, recruiting immune mediators that enable anti-tumor responses within and outside the radiation field. There has been a rapid expansion in the number of clinical trials harnessing radiation to enhance antitumor immunity. If po...
Autores principales: | Kang, Josephine, Demaria, Sandra, Formenti, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028964/ https://www.ncbi.nlm.nih.gov/pubmed/27660705 http://dx.doi.org/10.1186/s40425-016-0156-7 |
Ejemplares similares
-
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer
por: Redman, Jason M., et al.
Publicado: (2018) -
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
por: Zamarin, Dmitriy, et al.
Publicado: (2020) -
Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018) -
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
por: Grigg, Claud, et al.
Publicado: (2016) -
GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
por: DeNardo, David G, et al.
Publicado: (2021)